Japan Lifeline Co., Ltd. (FRA:L8B)

Market Cap	632.08M +4.5%
Revenue (ttm)	325.66M +5.7%
Net Income	50.39M +0.8%
EPS	0.76 +0.7%
Shares Out	n/a
PE Ratio	11.66
Forward PE	n/a
Dividend	0.43 (4.89%)
Ex-Dividend Date	Sep 29, 2026

Volume	n/a
Open	8.85
Previous Close	8.70
Day's Range	8.85 - 8.85
52-Week Range	6.65 - 8.85
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2026

About Japan Lifeline

Japan Lifeline Co., Ltd., a medical device company, engages in manufacturing and sale of medical device in Japan. The company’s cardiac rhythm management products include cardiac pacemakers, implantable cardioverter defibrillators, subcutaneous implantable cardioverter defibrillators, cardiac resynchronization therapy defibrillators and pacemakers, automated external defibrillators, and cardiopulmonary resuscitation support devices; and electrophysiology/ablation products comprise electrophysiological and ablation catheters, irrigated tip ablat...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1981
• Employees: 1,304
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: L8B

Financial Performance

In fiscal year 2026, Japan Lifeline's revenue was 59.19 billion, an increase of 4.55% compared to the previous year's 56.61 billion. Earnings were 9.35 billion, an increase of 0.35%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 26, 2026

Data Sources Report a data error